Interventional Radiology Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Interventional Radiology Market: By Product Type (Ultrasound imaging, CT scan, Angiography, MRI), By Technology (Angiography, Angioplasty, Biopsy, Others), By Application (Cardiology, Gastroenterology, Oncology, Urology & Nephrology), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Interventional Radiology Market size was valued at USD 26,254.3 million in 2021 and is expected to grow at a significant CAGR of 5.3% during the forecast period 2022 to 2028. The global market provides a detailed overview of the market and that can be segmented by product type, technology, application, end user, and region. By product type, The Interventional radiology market has been segmented into ultrasound imaging, CT scan, angiography, and MRI. The MRI segment is likely to be the largest and fastest-growing segment due to various factors such as technological advancements and new product launches. Based on technology, the Interventional radiology market is segmented into angiography, angioplasty, biopsy, and others. Among these, the angiography segment is expected to have the fastest-growing market over the forecast period 2022-2028, due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally complex procedures. Based on application, the Interventional radiology market is segmented into cardiology, gastroenterology, oncology, urology, & nephrology. The oncology segment is anticipated to witness the highest CAGR during the forecast period due to the rising incidence of cancer and increasing demand for minimally invasive procedures. Based on the end user, the segment has been segregated into hospitals, ambulatory surgical centers, and others. The hospital segment is expected to dominate due to rising patient populations worldwide, and rising various clinical trials over various diseases.

Key Development:

In December 2020, Samsung Electronics Co. Ltd launched its premium diagnostic imaging solutions in ultrasound, digital radiography, and mobile computed tomography at the Radiological Society of North America (RSNA) 2020. This strategic initiative assisted the company in expanding its product portfolio in the interventional radiology industry.

In April 2022, GE Healthcare and Medtronic announced a collaboration to meet the growing need for outpatient care and focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs).

Interventional Radiology Market

MARKET SUMMARY
-
5.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.3%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Interventional Radiology Market

  • The report on global interventional radiology market gives historical, current and future market sizes (US$ Mn) based on product type, procedures, application and end user.
  • interventional radiology market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Hologic, Inc.
  • Fujifilm Corporation
  • Samsung Medison
  • Shimadzu Corporation
  • Carestream Health, Inc.
  • Esaote S.p.A
Interventional Radiology Market Drivers

Rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and technological advancements are anticipated to propel the market growth over the forecast years. Moreover, the risk of high radiation exposure is a serious concern for MRI manufacturers & healthcare facilities are hindering the market growth during the forecast years.


North-America got significant share

Interventional Radiology Market

North America market is expected to witness the highest market share during the forecast period owing to the rising prevalence of chronic diseases and the elderly age population.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The interventional radiology market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Interventional Radiology Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

An increase in the patient population, more inclusion of minimally invasive treatment procedures, and the availability of cost-effective techniques.

An increasing patient population and a rising aging population are expected to create lucrative growth opportunities during the forecasted period.

The global market for interventional radiology surpassed USD 26,254.3 million in 2021 and is anticipated to grow at a CAGR of 5.3% from 2022 to 2028, primarily driven by the rising prevalence of chronic diseases and consequent demand for X-ray vision, quality scanning, and treatment devices.

Based on product, The MRI segment is registered as the fastest-growing segment. As, MRI is an effective method used for the treatment of various diseases such as anomalies of the brain & spinal cord, tumors, cysts, cancers, cardiovascular disorders, etc.


Report

Table Of Content


Report

Company Profile

  • Hologic, Inc. (U.S.)
  • Fujifilm Corporation (Japan)
  • Samsung Medison (South Korea)
  • Shimadzu Corporation (Japan)
  • Carestream Health, Inc. (U.S.)
  • Esaote S.p.A (Italy)
  • GE Healthcare (General Electric Company) (U.K.)
  • Siemens Healthcare GmBH (Siemens AG) (Germany)
  • Koninklijke Philips N.V. (The Netherlands)

Description

Interventional Radiology Market size was valued at USD 26,254.3 million in 2021 and is expected to grow at a significant CAGR of 5.3% during the forecast period 2022 to 2028. The global market provides a detailed overview of the market and that can be segmented by product type, technology, application, end user, and region. By product type, The Interventional radiology market has been segmented into ultrasound imaging, CT scan, angiography, and MRI. The MRI segment is likely to be the largest and fastest-growing segment due to various factors such as technological advancements and new product launches. Based on technology, the Interventional radiology market is segmented into angiography, angioplasty, biopsy, and others. Among these, the angiography segment is expected to have the fastest-growing market over the forecast period 2022-2028, due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally complex procedures. Based on application, the Interventional radiology market is segmented into cardiology, gastroenterology, oncology, urology, & nephrology. The oncology segment is anticipated to witness the highest CAGR during the forecast period due to the rising incidence of cancer and increasing demand for minimally invasive procedures. Based on the end user, the segment has been segregated into hospitals, ambulatory surgical centers, and others. The hospital segment is expected to dominate due to rising patient populations worldwide, and rising various clinical trials over various diseases.

Key Development:

In December 2020, Samsung Electronics Co. Ltd launched its premium diagnostic imaging solutions in ultrasound, digital radiography, and mobile computed tomography at the Radiological Society of North America (RSNA) 2020. This strategic initiative assisted the company in expanding its product portfolio in the interventional radiology industry.

In April 2022, GE Healthcare and Medtronic announced a collaboration to meet the growing need for outpatient care and focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX